ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $36,000 | -53.8% | 24,150 | -50.9% | 0.00% | -57.1% |
Q2 2020 | $78,000 | +239.1% | 49,150 | +103.5% | 0.01% | +133.3% |
Q1 2020 | $23,000 | -83.2% | 24,150 | -51.8% | 0.00% | -75.0% |
Q4 2019 | $137,000 | +35.6% | 50,150 | +95.5% | 0.01% | +20.0% |
Q3 2019 | $101,000 | +60.3% | 25,650 | +66.6% | 0.01% | +66.7% |
Q2 2019 | $63,000 | – | 15,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deer VII & Co. Ltd. | 2,263,365 | $15,889,000 | 50.04% |
TRV GP II, LLC | 2,790,964 | $19,593,000 | 12.78% |
FRAZIER MANAGEMENT LLC | 3,330,373 | $23,379,000 | 5.63% |
Partner Investment Management, L.P. | 296,961 | $2,085,000 | 2.41% |
SPHERA FUNDS MANAGEMENT LTD. | 431,193 | $3,027,000 | 0.28% |
PFM Health Sciences, LP | 1,463,208 | $10,272,000 | 0.23% |
Perceptive Advisors | 132,300 | $929,000 | 0.03% |
Fosun International Ltd | 29,877 | $209,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,200 | $584,000 | 0.01% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 343,574 | $2,412,000 | 0.01% |